pACYC-TtCas6-4xcrRNA4.5 Citations (2)

Originally described in: Target preference of Type III-A CRISPR-Cas complexes at the transcription bubble.
Liu TY, Liu JJ, Aditham AJ, Nogales E, Doudna JA Nat Commun. 2019 Jul 5;10(1):3001. doi: 10.1038/s41467-019-10780-2. PubMed Journal

---

Articles Citing pACYC-TtCas6-4xcrRNA4.5

Articles
Intrinsic signal amplification by type III CRISPR-Cas systems provides a sequence-specific SARS-CoV-2 diagnostic. Santiago-Frangos A, Hall LN, Nemudraia A, Nemudryi A, Krishna P, Wiegand T, Wilkinson RA, Snyder DT, Hedges JF, Cicha C, Lee HH, Graham A, Jutila MA, Taylor MP, Wiedenheft B. Cell Rep Med. 2021 Jun 15;2(6):100319. doi: 10.1016/j.xcrm.2021.100319. Epub 2021 May 27. PubMed
Sequence-specific capture and concentration of viral RNA by type III CRISPR system enhances diagnostic. Nemudraia A, Nemudryi A, Buyukyoruk M, Scherffius A, Zahl T, Wiegand T, Pandey S, Nichols J, Hall L, McVey A, Lee H, Wilkinson R, Snyder L, Jones J, Koutmou K, Santiago-Frangos A, Wiedenheft B. Res Sq. 2022 Apr 19. doi: 10.21203/rs.3.rs-1466718/v1. PubMed

If you have published an article using this material, please email us at to have your article added to this page.